Research programme: small molecule therapeutics - Petra Pharma

Drug Profile

Research programme: small molecule therapeutics - Petra Pharma

Alternative Names: PETRA-01

Latest Information Update: 16 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Petra Pharma
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Enzyme modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Cancer; Metabolic disorders

Most Recent Events

  • 11 Apr 2018 Petra Pharma and Evotec AG enter research collaboration to develop PETRA 01 for Cancer
  • 11 Apr 2018 Petra Pharma announces intention to submit IND application for PETRA 01 with the US FDA for Cancer by end of 2018
  • 19 Sep 2017 Petra Pharma in-licenses computational drug discovery platform technology from Schrodinger
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top